<--- Back to Details
First PageDocument Content
Robert Yarchoan / Didanosine / Zidovudine / National Institutes of Health / Robert Gallo / Oceanside /  New York / AIDS / Retrovirus / Human T-lymphotropic virus 1 / Medicine / Health / HIV/AIDS
Date: 2004-07-09 13:33:00
Robert Yarchoan
Didanosine
Zidovudine
National Institutes of Health
Robert Gallo
Oceanside
New York
AIDS
Retrovirus
Human T-lymphotropic virus 1
Medicine
Health
HIV/AIDS

This is an oral history interview with Dr

Add to Reading List

Source URL: history.nih.gov

Download Document from Source Website

File Size: 704,94 KB

Share Document on Facebook

Similar Documents

UNITED STATES of AMERICA  EXPERT HIV HEALTHCARE AHF’s path to becoming the largest provider of HIV/AIDS care in the U.S. began with a small group of dedicated activists in Los Angeles in the 1980s who had a simple

UNITED STATES of AMERICA EXPERT HIV HEALTHCARE AHF’s path to becoming the largest provider of HIV/AIDS care in the U.S. began with a small group of dedicated activists in Los Angeles in the 1980s who had a simple

DocID: 1rhxq - View Document

Principles of collaboration SHCS_NICER_v5-1_NICER__Approved_Nov10

Principles of collaboration SHCS_NICER_v5-1_NICER__Approved_Nov10

DocID: 1r7HF - View Document

June 17, 2009   Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

June 17, 2009  Chemicals Targeting an HIV‐1 Nef/Host Cell Kinase Complex as Novel Anti‐ Retroviral Compounds    Damilola A. Adepegba, Department of Natural Sciences, University of Maryland 

DocID: 1qLnJ - View Document

Title Authors Affiliations

Title Authors Affiliations

DocID: 1qIsB - View Document

Dormant copies of HIV mostly defective, new study shows

Dormant copies of HIV mostly defective, new study shows

DocID: 1qAMy - View Document